ClinConnect ClinConnect Logo
Search / Trial NCT04210089

Total Contact Soft Cast in Diabetic Foot Ulcers

Launched by UNIVERSITY OF MINNESOTA · Dec 20, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called the total contact soft cast for people who have diabetic foot ulcers. Diabetic foot ulcers are sores or wounds that can develop on the feet of individuals with diabetes, and the goal of this trial is to see how well this special cast helps heal these ulcers. Researchers want to find out if the cast is easy to use, safe, and comfortable for patients, as well as how well patients stick to the treatment plan.

To participate in this trial, you need to be an adult with a diabetic foot ulcer. However, there are some restrictions: you cannot join if you have allergies to certain materials used in the cast, if you cannot have your leg wrapped, or if you are unable to attend weekly check-ups. Participants can expect regular visits where their progress will be monitored, and they will receive care for their ulcer as part of the study. This trial is currently recruiting participants, and everyone is welcome regardless of gender.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Any adult with a diabetic foot ulcer
  • Exclusion Criteria:
  • Allergy to Calamine or Zinc oxide
  • Inability to have leg wrapped
  • Inability to be seen weekly or as needed
  • Unable or unwilling to consent
  • Prisoners
  • Persons lacking capacity to consent

About University Of Minnesota

The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.

Locations

Minneapolis, Minnesota, United States

Patients applied

0 patients applied

Trial Officials

Joseph Schuster, DPM

Principal Investigator

University of Minnesota

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials